Stay updated with breaking news from Precigen Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Precigen, Inc. (NASDAQ:PGEN – Get Free Report) have been given a consensus rating of “Moderate Buy” by the five ratings firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average twelve-month target […]
Cantor Fitzgerald restated their overweight rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a research note released on Wednesday morning, Benzinga reports. Cantor Fitzgerald also issued estimates for Precigen’s FY2024 earnings at ($0.36) EPS. Several other research firms have also recently commented on PGEN. Stifel Nicolaus reissued a buy rating and issued a […]
In this article, we will discuss the 10 stocks recently downgraded by analysts.
HC Wainwright reissued their buy rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a $6.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Precigen’s Q1 2024 earnings at ($0.09) EPS, Q2 2024 earnings at ($0.09) EPS, […]
HC Wainwright reaffirmed their buy rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a report issued on Wednesday, Benzinga reports. HC Wainwright currently has a $6.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Precigen’s Q1 2024 earnings at ($0.09) EPS, Q2 2024 earnings at ($0.09) EPS, Q3 […]